Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis
Multiple Sclerosis Journal · 2024
DOI: 10.1177/13524585241292802 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Multiple Sclerosis Journal, 2024. Verfasst von Yuan Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neuroscience, The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Testosterone, Multiple Sclerosis, Genome-Wide Association Study. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Karolinska Institutet.
Abstract (Originalsprache)
Background
Women have a higher risk of developing multiple sclerosis (MS), potentially due to hormonal factors. Elevated testosterone levels, common in polycystic ovary syndrome (PCOS), might influence MS risk.
Objective
To investigate the relationship between PCOS, as a proxy for elevated testosterone levels, and MS risk through phenotypic and genomic analysis.
Methods
Cox regression models analysed the association between PCOS and MS risk. The genome-wide cross-trait analysis examined the genetic architecture.
Results
In a Swedish cohort of 1,374,529 women, 77 (0.3%) with PCOS and 3,654 (0.3%) without PCOS were diagnosed with MS. After adjusting for birth year and obesity, no association was found between PCOS and MS ( HR = 0.91, 95% CI = 0.72–1.15), which was confirmed by Mendelian randomization analysis, where genetically predicted PCOS propensity, sex hormone-binding globulin (SHBG), or testosterone levels did not causally affect MS risk (all p-values > 0.05). By exploring horizontal pleiotropy, we identified shared genetic regions and 19 independent pleiotropic SNPs for SHBG with MS and 11 for testosterone with MS.
Conclusion
We did not find evidence for a causal role of PCOS, as a proxy of elevated testosterone, in reducing the risk of MS in women. The shared genetic loci between testosterone, SHBG, and MS provide biological insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Neuroscience, The Karolinska Neuroimmunology & Multiple Sclerosis Centre, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
- Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
- Research Department of Primary Care & Population Health, University College London, London, UK.
- Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Yuan Jiang, Elaine Kingwell, Pernilla Stridh, Ingrid Kockum, Ali Manouchehrinia
Förderung
- Karolinska Institutet
Zitieren
APA
Jiang, Y., Cesta, C. E., Liu, Q., Kingwell, E., Stridh, P., Shchetynsky, K., Olsson, T., Kockum, I., Stener-Victorin, E., Jiang, X., & Manouchehrinia, A. (2024). Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241292802
Vancouver
Jiang Y, Cesta CE, Liu Q, Kingwell E, Stridh P, Shchetynsky K, et al. Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis. Multiple Sclerosis Journal. 2024. doi:10.1177/13524585241292802
BibTeX
@article{Jiang2024,
author = {Jiang, Yuan and Cesta, Carolyn E and Liu, Qianwen and Kingwell, Elaine and Stridh, Pernilla and Shchetynsky, Klementy and Olsson, Tomas and Kockum, Ingrid and Stener-Victorin, Elisabet and Jiang, Xia and Manouchehrinia, Ali},
title = {Exploring the relationship between polycystic ovarian syndrome, testosterone, and multiple sclerosis in women: A nationwide cohort study and genome-wide cross-trait analysis},
journal = {Multiple Sclerosis Journal},
year = {2024},
doi = {10.1177/13524585241292802}
}
EUVIMED